Rhythm Pharmaceuticals Inc (RYTM) Actualités

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update

-- Third quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $33.3 million -- -- Adult...

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024

-- Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8...

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

BOSTON and LONDON, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) and Axovia...

Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024

-- Five posters to be presented at ObesityWeek® -- BOSTON, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rhythm...

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage...

Form 8-K - Current report

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Rhythm Pharmaceuticals Announces FDA Acceptance for Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide) in Patients as Young as 2 years old

-- Label expansion sought to treat younger children with Bardet-Biedl syndrome or POMC/LEPR deficiency...

Rhythm Pharmaceuticals to Present at Wells Fargo Healthcare Conference in September

BOSTON, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage...

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage...